CYRAD: a translational study assessing immune response to radiotherapy by photons or protons in postoperative head and neck cancer patients through circulating leukocyte subpopulations and cytokine levels
The CYRAD trial is registered from October 19, 2021, at the US National Library of Medicine, ClinicalTrials.gov ID NCT05082961.
Authors
- Jean‐Michel Grellard (ORCID: https://orcid.org/0000-0001-7997-5027)
- Mathieu Césaire (ORCID: https://orcid.org/0000-0002-8931-000X)
- Bénédicte Clarisse (ORCID: https://orcid.org/0000-0002-0543-732X)
- Juliette Thariat (ORCID: https://orcid.org/0000-0003-4755-496X)
- Nathalie Rousseau (ORCID: https://orcid.org/0000-0001-5303-6697)
- Julie Coupey
- Samuel Valable (ORCID: https://orcid.org/0000-0003-0355-0270)
- Thao-Nguyen Pham
Institutions
- Centre National de la Recherche Scientifique (FR)
- Centre François Baclesse (LU)
- Laboratoire de Physique de Clermont Auvergne (FR)
- Normandie Université (FR)
- Laboratoire de Physique Corpusculaire de Caen (FR)
- Centre François Baclesse (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1186/s12885-024-13002-1
- Citations
- 2
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Ligue Contre le Cancer